Evaluation of Minimally Invasive Ilium Osteotomy and Its Bone Repairing Effect

NCT ID: NCT04926896

Last Updated: 2023-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

336 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-20

Study Completion Date

2024-12-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this research, a new bone harvesting technique is introduced in order to find an iliac crest bone harvesting method for patients with less trauma, less postoperative pain in donor sites, and lower incidence of postoperative complications, so as to get ideal bone grafting materials at a small cost, enhance the effect of osteogenesis repair on bone defect or fusion site, and improve the operation quality.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Based on the domestic and foreign research on minimally invasive bone harvesting, we have developed a disposable battery-powered bone harvesting device that can be used for milling bone tissues. Using this disposable battery-powered bone harvesting device, cancellous bone milling can be performed in a small bone hole with a diameter of 7.5 mm. The morselized bone or bone chips it milled can be used for bone fusion at the desired site. The technique adopts patented milling tool bit and electric drive, with high operation efficiency, so the surgery can be completed very quickly. The bone trauma in the operation can be significantly reduced and the pain in the donor site can be greatly alleviating. Moreover, the technique can obviously reduce the duration of bone harvesting and the cost of operating room. In addition, significant reductions in postoperative pain will also be helpful to a range of clinical advantages and benefits, such as the average hospitalization days, and will be expected to benefit significantly in patients undergoing autologous bone harvesting.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Control Group

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Experimental group:

Minimally invasive bone harvesting surgery group.

Control group:

Traditional iliac crest bone harvesting surgery group.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Minimally invasive bone harvesting surgery

1. .Applying routine approach in iliac crest bone harvesting surgery, make a 4cm long incision before or after the iliac crest, slice skin and subcutaneous tissue by layer., exposing the iliac crest ridge, outer plate and part of the iliac crest bone.
2. Use the cortical bone opening device to open two bone holes with a diameter of 7.5 mm side by side in the iliac bone cortex ,place disposable battery-powered bone harvesting device for iliac crest bone harvesting operations.
3. The direction of the tool bit should be parallel to the outer iliac plate, to avoid penetration of inner iliac layer, and avoid the injury to iliac blood vessels, nerves or internal organs.
4. .Scrap and collect the cancellous bone by tool bit during operation.
5. . After collecting sufficient amount of cancellous bone, turn off the power, screw out the cabin, and pour out the cancellous bone.
6. . Suturing the iliac crest periosteum and deep fascia, closing the incision layer by layer, no drainage.

Group Type EXPERIMENTAL

Minimally invasive bone harvesting surgery

Intervention Type PROCEDURE

Minimally invasive bone harvesting surgery

Traditional iliac crest bone harvesting surgery

1. .Applying routine approach in iliac crest bone harvesting surgery, make a 4cm long incision before or after the iliac crest, slice skin and subcutaneous tissue by layer., exposing the iliac crest ridge, outer plate and part of the iliac crest bone.
2. Use a bone chisel to open a lid on the iliac crest ridge cortex ,open the cover length at 3cm.
3. Lift the iliac crest ridge cortex plate cover, use bone knife and scraper to harvest bone in the iliac bone marrow cavity.
4. Avoid violence when using bone knives and scrapers, to avoid penetration of inner iliac layer, and avoid the injury to iliac blood vessels, nerves or internal organs.
5. After collecting sufficient amount of cancellous bone, suturing the iliac crest periosteum and deep fascia, closing the incision layer by layer, no drainage

Group Type PLACEBO_COMPARATOR

Traditional iliac crest bone harvesting surgery

Intervention Type PROCEDURE

The experimental group and the control group do not have special requirements; perform the surgery according to the normal operation methods of different sites.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Traditional iliac crest bone harvesting surgery

The experimental group and the control group do not have special requirements; perform the surgery according to the normal operation methods of different sites.

Intervention Type PROCEDURE

Minimally invasive bone harvesting surgery

Minimally invasive bone harvesting surgery

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients with clinical bone defects or need for bone fusion;
2. Age 18 to 65, and gender is not limited;
3. Informed consent has been signed.

Exclusion Criteria

1. Age less than 18 or greater than 65;
2. Patients with severe deformities of the iliac bone or extensive defects of the iliac bone, which are not suitable for bone extraction;
3. Patients with coagulation dysfunction;
4. Patients who are unwilling to perform iliac bone extraction;
5. BMI \& lt; = 18.5 kg/m2;
6. Patients with type I and type II diabetes;
7. Osteoporosis(T \& lt; = -2.5);
8. Moderate and severe anemia(hemoglobin \& lt; 9g/L) or hypoproteinemia(albumin \& lt; 30g/L);
9. Patients with malignant neoplasms; Patients with mental illness and those who are unconscious and unable to express themselves accurately.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

West China Hospital

OTHER

Sponsor Role collaborator

Werner Wicker Klinik

NETWORK

Sponsor Role collaborator

Tongji Hospital

OTHER

Sponsor Role collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yan Y Shigui, Professor

Role: STUDY_DIRECTOR

Chief Scientist

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hangzhou Xinrun Medical Technology Co., Ltd.

Hangzhou, Zhejiang, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Li L Wanli, M.D.

Role: CONTACT

13967116021

Li L Hongmei

Role: CONTACT

13857139616

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Li L Wanli, M.D.

Role: primary

13967116021

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-254

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.